GoldenGolden
Advanced Search
Agent Capital

Agent Capital

A biotech venture capital firm in Massachusetts that invests in seed and early stage ventures

Agent Capital is a biotech venture capital firm in Massachusetts that invests in seed and early stage ventures. Its portfolio companies include ImCheck Therapeutics, Pyxis Oncology, Entrada Therapeutics, Verge Genomics, Pliant Therapeutics, Carisma Therapeutics, Skyhawk Therapeutics, Precision BioSciences and Orchard Therapeutics. It usually invests in Series A, B and C rounds.

Agent Capital is a healthcare venture capital firm focused on companies that develop novel, differentiated therapeutics and treatments that address unmet patient needs.

Timeline

2017
Founded

People

Name
Role
LinkedIn

Bruce Peacock

VENTURE PARTNER

Geeta Vemuri, PhD, MBA

MANAGING PARTNER

John Glasspool

VENTURE PARTNER

Preston Noon, PharmD, MBA

PARTNER

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Carisma Therapeutics

Entrada Therapeutics

ImCheck Therapeutics

Orchard Therapeutics

Pliant Therapeutics

Precision BioSciences

Pyxis Oncology

Skyhawk Therapeutics

Verge Genomics

News

Title
Author
Date
Publisher
Description
FinSMEs
August 19, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.